Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
Completed · Phase 1
Conditions studied: Immune Response
In brief
Our group has shown that HAART increases the thymic production of naïve T cells in the healthy adult, thereby boosting the immune system. We propose to investigate the amount of and length of Nelfinavir therapy necessary to increase those cells in adults. Subjects will be treated with Nelfinavir, and blood will be sampled at variable times to determine the immune response in peripheral blood.
Key facts
- Study ID
- NCT00346619
- Run by
- Mayo Clinic
- People needed
- 25
- Starts
- 2005-10-01
- Expected to finish
- 2007-10-01
- Last updated by the study team
- 2010-01-20
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.